- Home
- ARQT vs SA Comparison
ARQT vs SA Comparison
Compare ARQT & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | SA |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.4B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ARQT | SA |
|---|---|---|
| Price | $20.44 | $30.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $34.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 1.8M | 736.6K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,072,000.00 | N/A |
| Revenue This Year | $34.85 | N/A |
| Revenue Next Year | $29.39 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.72 | $11.93 |
| 52 Week High | $31.77 | $40.06 |
Technical Indicators
Market Signals| Indicator | ARQT | SA |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 50.41 |
| Support Level | $19.60 | $27.64 |
| Resistance Level | $24.56 | $32.70 |
| Average True Range (ATR) | 1.27 | 1.69 |
| MACD | -0.20 | -0.12 |
| Stochastic Oscillator | 23.32 | 51.06 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration and development of gold properties situated in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, the Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.